Armo Biosciences Inc. (ARMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||
| Net Income | -42,425 | -33,624 | -27,470 |
| Depreciation Amortization | 200 | 207 | 204 |
| Accounts payable and accrued liabilities | -1,733 | 4,908 | 587 |
| Other Working Capital | -3,633 | 4,113 | 1,092 |
| Other Operating Activity | 2,866 | -3,980 | -13 |
| Operating Cash Flow | $-44,725 | $-28,376 | $-25,600 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -21 | -108 | -85 |
| Investing Cash Flow | $-21 | $-108 | $-85 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | -6 | -20 | 5 |
| Other Financing Activity | 67,490 | 9,991 | 54,497 |
| Financing Cash Flow | $67,484 | $9,971 | $54,502 |
| Beginning Cash Position | 26,737 | 45,250 | 16,433 |
| End Cash Position | 49,475 | 26,737 | 45,250 |
| Net Cash Flow | $22,738 | $-18,513 | $28,817 |
| Free Cash Flow | |||
| Operating Cash Flow | -44,725 | -28,376 | -25,600 |
| Capital Expenditure | -21 | -108 | -85 |
| Free Cash Flow | -44,746 | -28,484 | -25,685 |